Funder
National Science Council of Taiwan
Chi-Mei Medical Center Research Foundation
Subject
Infectious Diseases,Microbiology (medical),General Immunology and Microbiology,General Medicine,Immunology and Allergy
Reference31 articles.
1. Carbapenems versus alternative antibiotics for the treatment of bacteremia due to Enterobacteriaceae producing extended-spectrum beta-lactamases: a systemic review and meta-analysis;Varjakas;J Antimicrob Chemother,2012
2. Carbapenem therapy is associated with improved survival compared with piperacillin-tazobactam for patients with extended-spectrum β-lactamase bacteremia;Tamma;Clin Infect Dis,2015
3. Carbapenem resistance among Klebsiella pneumoniae isolates: risk factors, molecular characteristics, and susceptibility patterns;Hussein;Infect Control Hosp Epidemiol,2009
4. In vitro activity of fosfomycin against blaKPC-containing Klebsiella pneumoniae isolates, including those non-susceptible to tigecycline and/or colistin;Edimiani;Amtimicrob Agents Chemother,2010
5. What remains against carbapenem-resistant Enterobacteriaceae? Evaluation of chloramphenicol, ciprofloxacin, colistin, fosfomycin, minocycline, nitrofurantoin, temocillin and tigecycline;Livermore;Int J Antimicrob Agents,2011